S230815
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for S230815, covering 2026-02-11 to 2026-02-11. Get the full timeline:
Most recent: Clinical Trial Update: A First-in-human Study of S230815 in Pediatric Participants With KCNT1-related Developmental and Epileptic Encephalopathy [Phase 1, Phase 2]